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PORTAL CD4+ AND CD8+ T LYMPHOCYTE CORRELATE TO INTENSITY OF INTERFACE HEPATITIS IN
CHRONIC HEPATITIS C
Ana Teresa Rodriguez VISO(1), Thaís de Castro BARBOSA(2), Lídia YAMAMOTO(3), Carla PAGLIARI(4), Elaine Raniero FERNANDES(5), Roosecelis Araújo BRASIL(5),
Heitor Franco de ANDRADE JUNIOR(6), Maria Irma Seixas DUARTE(6) & Antônio Alci BARONE(1)
SUMMARY
Background. The pathogenesis of chronic hepatitis C is still a matter of debate. CD4+ and CD8+ T lymphocytes (TL) are
typically observed within the portal and periportal spaces of affected livers, but their functional role in hepatitis C progression has
not been fully elucidated. Methods. CD4+ and CD8+ TL were quantified by immunohistochemistry in portal and periportal
spaces of 39 liver biopsies from patients with chronic hepatitis C. They were associated to demographic data, histological parameters,
laboratory findings of patients and hepatitis C genotypes. Results. There was high numbers of CD4+ and CD8+ TL from which the
density of CD4+ T was higher than CD8+ TL in portal and periportal spaces. CD4+ and CD8+ TL were directly correlated to
intensity of interface hepatitis. CD8+ TL correlated to serum enzyme levels. Conclusion. The high numbers of CD4+ and CD8+
TL in portal and periportal spaces and their correlation to interface hepatitis suggest that hepatitis C evolution depends on the
action of intrahepatic T lymphocytes, lending support to the notion of an immune-mediated mechanism in the pathogenesis of
chronic hepatitis C.
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INTRODUCTION
Chronic hepatitis C (CHC) is a Public Health problem that involves
about 170 million people infected worldwide, being the main cause of
liver transplants in developed countries30. In Brazil, it is estimated that
there are at least three million subjects with CHC, making up 2.5 to
4.9% of the country’s population15.
Human hepatitis C virus (HCV) infection results in chronic disease
in almost three quarters of infected individuals30. Most patients present
blood chemistry and histology compatible with mild38 or moderate
necro-inflammatory activity and 20% of them can progress to cirrhosis30.
Early reports considered a direct cytopathic effect of HCV as the
primary form of liver injury caused by the virus itself6, similarly to the
findings with other flaviviruses31 and subsequent studies raised the
possibility of genotype 1a being more pathogenic3,43. Other studies on
the chronic phase of HCV infection did not favor the cytopathic
hypothesis16 and showed that the hepatic lesions were mediated by a
hyper reactive immune response1,19,36. This issue is still controversial
and, in some situations, one or the other mechanism might predominate
in the HCV infected patient.
The severity of hepatitis and the perpetuation of chronic HCV
infection were related to T cell activation in the liver1 and cytokine
production by activated CD4+ or CD8+ T lymphocytes (TL)26. Those
cells could be viewed only as markers of HCV infection or to be
involved in the progression of liver disease12,14. The reason for the
persistence of HCV in most cases of acute infection by hepatitis C
virus that progress to chronic infection is uncertain27 but viral clearance
in acute infection has been attributed to the reactivity of cytotoxic TL,
with an inefficient and poor humoral response to HCV20.
This work compares the quantitative in situ expression of CD4+
and CD8+ TL in the portal and periportal spaces of liver tissue from
patients with CHC. In addition, the cell density of these two TL
subpopulations were associated to demographic, histology and
biochemical data as well to HCV genotypes.
PATIENTS AND METHODS
Patients: From August 2001 through August 2002, thirty-nine
CHC patients were selected during their sequential attendance at an
Outpatients Hepatitis Centre in the General Hospital of the School
of Medicine of the University of São Paulo (HC FMUSP). All patients
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selected were between 18 and 60 years old, of both genders. The
race or ethnicity was classified according to IBGE (Brazilian Institute
of Geography and Statistics)23, a Brazilian measurement of the skin
color40, defined as: white, black and “pardo” - translated earlier as
“mulatto”8.
The inclusion criteria for the selection of patients were: positive
HCV serology (second or third generation ELISA) confirmed by
positive polymerase chain reaction (PCR) for HCV, elevate ALT (alanine
aminotransferase) levels at least 1.5 times the upper normal limit (UNL)
collected until two months before the hepatic biopsy (nearest date)
and liver biopsy indicative of CHC according to Ishak classification25.
The quantification of HCV RNA was not available in the “Hospital
das Clinicas” in the period of selection of the patients.
The exclusion criteria for the selection of patients were: alcohol
abuse in the last six months before the liver biopsy; previous infection
by HIV or HTLV; use of corticosteroids in the last six months before
the liver biopsy; previous HCV treatment (use of interferon or ribavirin);
presence of other liver diseases such as hepatitis B infection, drug
hepatotoxicity, alpha 1 antitrypsin deficiency, Wilson’s disease,
hemochromatosis, autoimmune hepatitis and liver neoplasms.
The procedures used were approved by the Research Ethics
Committee of “Hospital das Clinicas”. All the selected patients gave
their signed informed consent.
Liver biopsies: Percutaneous liver biopsies were performed for
patient diagnosis using a tru-cut needle under local anesthesia. Biopsy
liver fragments should be at least 1 cm long or 10 portal spaces. They
were submerged in 10% buffered formalin and sent to the Laboratory
of Pathology of Transmissible Diseases for paraffin embedding and
routine staining with hematoxylin and eosin, Masson´s trichrome,
reticulin, Perls, and also immunohistochemical staining. The samples
of liver that were insufficient were excluded from this research. All
preparations were analyzed by two independent trained pathologists.
The liver biopsies were analyzed according to Ishak Classification25
because it is the most detailed, accepted internationally and can be
compared to other classifications, as METAVIR37. Ishak classification
is divided into the grading of necroinflammatory scores and the staging.
The necroinflammatory scores are classified in: periportal ou periseptal
interface hepatitis (grading from 0 to 4); confluent necrosis (grading
from 0 to 6); focal lytic necrosis, apoptosis and focal inflammation
(grading from 0 to 4) and portal inflammation (grading from 0 to 4).
The staging is defined by architectural changes, fibrosis and cirrhosis
(grading from 0 to 6).
Immunohistochemistry: Immunohistochemistry reactions were
performed to detect CD4+ TL (anti-human CD4 clone OPD4 M834/
Dako Corporation, Carpinteria, CA) and CD8+ TL (anti-human clone
OPD8 M7103/ Dako Corporation, Carpinteria, CA). The Catalysed
Signal Amplification-CSA (K1500/Dako), based on the peroxidase
catalysed deposition of a biotinylated phenolic compound, was used
to better visualize positive cells. Sections were dewaxed in xylene and
hydrated through a graded ethanol series. After this, 3% hydrogen
peroxide was used to block endogenous peroxidase. Primary anti-CD4
and anti-CD8 mouse antibodies were incubated overnight at 1:1000
and 1:50 dilutions, respectively. Biotinylated anti-mouse antibody was
applied for 15 minutes at 37 ºC. Peroxidase-labeled streptavidin-biotin
complex was applied for 15 minutes at 37 ºC, followed by the biotinyl
tyramide reagent for 15 minutes and a secondary reaction with
streptavidin peroxidase. 3,3 diamino-benzidine tetrahydrochloride
(SIGMA Chemical Company) was used as chromogen and the slides
were counterstained with Harris hematoxylin. Excluding the primary
antibodies, all the reagents were supplied with the CSA kit9,22. Positive
TL were visualized as brown in portal and peri-portal spaces.
Counting of CD4+ and CD8+ TL was done with an optical
microscope fitted with a square optical grid (1 cm2). Biopsy slides
were analyzed first with a 10x Plan Objective lens, and screening began
at the first portal space on the left upper extremity then moving to the
right and downwards, with the grid sequentially centered on each portal
space and surrounding area. Within each screening square, counting
of positive cells in the portal and periportal spaces was done at 400 x
magnification. At least five to 10 portal spaces were counted on each
slide. The number of positive cells was divided by the number of counted
spaces and this result was divided by 0.062541 and the final number
obtained represents the density of CD4+ or CD8+ TL in the portal and
peri-portal spaces of each liver biopsy.
HCV Genotyping: Genotype was determined using a Nested-PCR
purified product, delimited by primers NCR4. The samples were
processed in an automatic ABI Prism DNA Sequencer, using the ABI
Prism Big DyeTM Kit Terminator Cycle Sequencing Ready Reaction,
version 2.0 (Applied Biosystems). The obtained sequences were also
analyzed and compared with the HCV Data Base, referenced to Basic
Local Assignment Tool (BLAST), and the genotypes were compatible
with HCV7.
Statistical analysis: Quantitative and semi-quantitative data were
initially related using Pearson’s parametric correlation (expressed as
r) for ordinal or quantitative data, and Spearman rank correlation
(expressed as rs) for proportions. The quantitative data were separated
according to the ordinal classification, compared using variance analysis
(ANOVA) and confirmed by the Kruskal Wallis test. Event difference
was considered significant when the probability of equality was lower
than 0.05 (p < 0.05). Events were considered related when the
probability of absence of relationship was lower than 0.05 (p < 0.05).
RESULTS
The sample comprises 39 hepatic biopsies from patients with CHC.
All of the patients were selected according to inclusion and exclusion
criteria.
In Table 1, patient’s age varied between 25 and 53 years; gender
and ethnic distributions were: 25 (64%) males, 14 (36%) females; 30
(77%) white, 4 (10%) black and 4 (13%) “pardo” (according to IBGE
classification23).
Serum enzymes ALT, AST (aspartate transaminase) and GGT
(gamma-glutamyl transferase), collected the newest before liver biopsy,
ranged from one to seven times the UNL, with mean range 2.1 for
AST, 2.8 for ALT and 2.2 for GGT. The distribution of HCV genotypes
was: 22 (56.4%) patients with genotype 1b, six (15.3%) with genotype
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1a, two (5.1%) with genotype 2a, one (2.5%) with genotype 2b and
eight (20.5%) with genotype 3a (Table 1).
All patients presented architectural changes and portal
inflammation in the hepatic biopsy according to Ishak classification25,
with four (10%) patients architectural stage 5 and 6, six (16%) patients
architectural stage 3 and 4 and 29 (74%) patients architectural stage 1
and 2 (Table 1). Interface hepatitis was absent in 12 (30%) patients,
with grade 1 in 21 (55%) patients, grade 2 in four (10%) patients and
two (5%) patients grade 3. No confluent necrosis was found in this
sample (Table 1).
Figure 1 shows CD4+ and CD8+ TL stained in brown in
immunohistochemistry reactions (1A and 1B respectively). The number
of lymphocyte subpopulations in portal areas is shown in Table 1, with
mean of CD4+ TL 186.8 (varying from 57 to 2195.2 cells/sq mm2) and
CD8+ TL mean 48.7 (varying from 44.8 to 504 cells/sq mm2).
Interface hepatitis correlated to CD4+ TL (p 0.018) and CD8+ TL
(p 0.027) in portal and periportal areas (Table 2) and this relationship
was directly proportional as shown in Figures 2A and 2B. There was
no correlation between the CD4/CD8 ratio and interface hepatitis (Fig.
2C). The inflammatory activity in liver was grouped in the lower and
Table 1
Demographic and laboratory characteristics of 39 patients with CHC
Case Sex/ Race* AST** ALT** GGT** VHC Interface Portal Focal Staging TL TL CD4/
age genotype hepatitis inflam. necrosis CD4+ CD8+ CD8
1 F/27 white 7 1 1 1b 1 2 1 2 686.4 300.8 2.3
2 M/25 white 2 1 1 1b 0 2 1 2 438 332.8 1.3
3 M/45 black 2 1 1 1b 3 3 2 1 1110.4 360 3.1
4 M/45 white 4 1 1 1b 1 2 1 2 700.8 504 1.4
5 M/22 white 1 1 1 1b 0 1 1 1 57 204.8 4.4
6 F/23 white 1 2 1 1b 1 2 1 2 822.4 347.2 2.4
7 F/52 white 1 2 1 1b 0 1 1 1 432 262.8 1.6
8 M/47 black 1 2 1 1b 1 2 1 2 441.6 244.8 1.8
9 M/24 white 1 2 1 1b 1 1 2 2 702.4 115.2 6.1
10 M/44 pardo 2 2 1 1b 1 2 1 2 292.8 361.6 0.8
11 F/22 white 1 2 1 1b 0 2 1 1 395.2 134.4 2.9
12 M/25 “pardo” 1 2 1 1b 0 2 1 2 603.2 214.4 2.8
13 M/39 “pardo” 2 2 1 1b 1 2 1 2 1162.7 474.7 2.4
14 M/38 white 1 2 1 1b 1 2 2 1 1020.8 70.4 14.5
15 M/23 white 2 2 1 1b 1 2 1 3 672 244.8 2.7
16 M/48 black 4 2 1 3a 2 2 0 1 731.2 300.8 2.4
17 F/47 white 1 2 1 3a 0 2 0 1 304 198 1.5
18 M/29 white 1 2 1 1b 1 2 1 1 532.8 56 9.5
19 M/37 white 1 2 1 3a 1 2 1 1 651.2 148.8 4.4
20 M/30 “pardo” 1 2 1 1b 1 2 1 6 396.8 188.8 2.1
21 F/41 black 1 2 1 1a 1 3 1 5 283.2 44.8 6.3
22 M/58 white 2 3 1 1b 1 2 1 1 148.8 81.8 1.8
23 M/36 white 1 3 1 3a 1 2 1 1 448 75.2 5.9
24 M/41 white 1 3 1 3a 1 2 1 1 592 265.6 2.2
25 M/37 white 1 3 2 2a 0 1 1 1 593.6 128 4.6
26 F/52 white 6 3 2 1a 2 2 1 3 723.2 395.2 1.8
27 M/48 white 3 3 2 3a 2 2 1 5 1264 302.4 4.2
28 M/25 white 1 3 3 1a 0 1 1 1 617.6 168 3.7
29 F/59 white 5 3 3 1b 0 2 1 1 1139.2 355.2 3.2
30 M/48 “pardo” 5 3 3 1b 0 1 1 1 1048 169.6 6.2
31 M/20 white 1 4 4 1b 0 2 1 1 275.2 56 4.9
32 M/25 white 1 4 4 1a 1 2 1 1 811.2 102.4 7.9
33 F/49 white 1 4 4 1a 1 3 1 3 1276.8 118.4 10.8
34 M/27 white 2 4 4 2b 3 4 1 6 1408 419.2 3.3
35 M/35 white 4 4 4 1a 0 1 1 2 624 189 97.5
36 F/46 white 2 5 5 1b 1 2 1 3 534.4 228.8 2.3
37 F/49 white 4 6 6 3a 2 4 2 4 558.4 252.8 2.2
38 F/56 white 1 6 7 2a 1 2 1 3 2195.2 230.4 9.5
39 F/24 white 2 7 7 1b 1 1 1 1 510.4 70.4 7.2
*Race or ethnicity according to IBGE ; **number of times of ULN
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higher grades of activity of interface hepatitis, which means, the 33
(85%) patients with interface hepatitis grade 0 and 1 of Ishak
classification25 were grouped in the cathegory of low activity and the
six (15%) patients with grade 2 and 3 of Ishak classification25 were
classified as high activity (Fig. 2D). The higher interface activity was
correlated to CD4+ TL (p < 0.05) and CD8+ TL (p < 0.01) expression,
but not to the CD4/CD8 ratio (Fig. 2 D).
CD8+ TL correlated significantly to AST (p 0.003) and GGT (p
0.004). Such correlation was not observed for CD4+ TL (Table 2).
There was no significant association between lymphocyte
populations and age, gender, ethnicity or HCV genotype (Table 2).
There was no correlation between HCV genotypes and the
histological characteristics by Ishak classification in this casuistic. AST
was correlated significantly to CD8+ TL (p 0.012) and interface
hepatitis (p 0.052). The same correlation was not noticed for ALT.
GGT correlated to staging (p 0.001), portal inflammation (p 0.006)
and interface hepatitis (p 0.013).
DISCUSSION
This study shows the expression of CD4+ and CD8+ TL by
immunohistochemistry in the portal and periportal areas of hepatic
biopsies from patients with CHC, and the correlation between CD4+
and CD8+ TL densities and intensity of interface hepatitis. These results
suggest that intrahepatic TL have an active role in the pathogenesis of
CHC.
Most of the patients of this sample presented blood chemistry and
histology compatible with mild inflammatory lesions (Table 1),
similarly to what is generally described in CHC38.
We found a high prevalence of TL in the portal and periportal liver
areas, with CD4+ TL prevailing over CD8+ TL (Table 1). Many studies
show higher number of CD4+ than CD8+ LT and argue that the first
have a function similar to CD8+TL, a cytotoxic action in CHC4,5,10
besides an indirect action by cytokines production18. In this research
we did not analyzed the function of these cells, but we can infer that
the CD4+TL have an important participation in pathogenesis of chronic
hepatitis C. The expression of CD8+ TL in these patients corroborate
the notion of a cytotoxic mechanism participating in the hepatic lesions
in CHC because these lymphocytes are considered the main effector
cells in the hepatic lesion in chronic hepatitis C27 and capable of limiting
viral replication in patients with CHC17. The close relationship between
tissue CD8+ TL and both biochemical markers of hepatocyte injury as
the increase of ALT and GGT and histological findings of interface
hepatitis (Table 2) are other evidences of hepatic lesion by these cells,
similarly to the findings of others, who analyzed the gene expression
of CD8β in chronic hepatitis C patients29.
Two patients (cases 20 and 34) presented cirrhosis (grade 6 of
Ishak25), with CD4+ TL densities 396.8 and 1408 cells/sq mm2 and
CD8+ TL densities 419.2 and 188.8 cells/sq mm2 CD4+ and CD8+
and two other patients (cases 21 and 27) had pre-cirrhotic lesions (grade
5 of Ishak25), with CD4+ TL densities 283.2 and 1264 cells/sq mm2
and CD8+ TL cell densities 44.8 and 302.4 cells/sq mm2 (Table 1). In
these four cases there were marked changes in the hepatic architecture
but, despite the observational difficulties imposed by such alterations,
it has a tendency to higher numbers of the CD4+ and CD8+ TL
subpopulations. This analysis was limited by the small number of
advanced fibrosis in our patients.
Among the alterations that take place in the liver during chronic
disease caused by hepatotropic viruses, the most important is interface
hepatitis24, also known as periportal or periportal hepatitis, previously,
“piecemeal necrosis”25, due to the greater chance of progression of
fibrosis as seen in chronic hepatitis C24. Then, the patients were grouped
according to interface hepatitis into lower activity (grade 0 and 1 of
Ishak classification25) and higher activity (grade 2 and 3 of Ishak
classification25) and there was a significant and direct correlation
between interface hepatitis and the liver expression of CD4+ and CD8+
TL (Fig. 2D). Although it did not analyze whether these TL were HCV
specific, as shown in other studies26, the present observation correlates
the TL expression and interface hepatitis in patients with CHC strongly
suggesting a relationship between these cells and the progression of
CHC, advocating in favour of an intrahepatic immune response, as
argued by many researchers13,32,33,42.
Fig. 1 - Typical staining of immunohistochemistry detection of CD4+ (A) and CD8+ (B)
lymphocytes in portal areas. Magnification x 400 and 200 respectively. Arrows indicate
stained cells in brown.
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The significant positive correlation between portal and periportal
CD8+ LT expression and interface hepatitis (Fig. 2B) can be seen as
an evidence of the occurrence of a cytotoxic immune-mediated lesion.
It is possible that these lymphocytes are not able to destroy HCV
completely and the hepatic lesions subsequent to their action are enough
to cause interface hepatitis. Studies using cytotoxic assays with HCV
synthetic peptides have shown specific class I TL epitopes against HCV
in the inflammatory infiltrates of chronic hepatitis C livers2, suggesting
viral persistence despite the presence of immune T cell cytotoxicity.
Some authors criticize data from cells specifically stimulated in vitro
with viral CD8+ antigens, arguing that there is in fact a biased selection
of responsive cells in culture that would thus not reflect what actually
happens in vivo21. Quantitative assays similar to ours would contribute
greatly to the elucidation of CHC pathogenesis because they show the
actual intrahepatic response, within the natural environment of cellular
participants21. Some studies found a correlation between AST and
interface hepatitis28 or AST and progression of fibrosis in CHC30. In
this research the AST was correlated significantly to CD8+ and interface
hepatitis, besides the GGT correlated to staging, portal inflammation
and interface hepatitis. These pieces of evidence support the notion
that AST results from an hepatic lesion and that this is probably due to
CD8+ TL action.
Many host factors have been observed to increase the risk of
progression of liver disease, such as the later age of acquisition of
hepatitis C, male gender35 and afro-descendants39, but we could not
Fig. 2 - In situ CD4+ and CD8+ lymphocytes quantification in portal and periportal areas in hepatic biopsies according the score of interface hepatitis (or piecemeal necrosis). A. CD4+ TL
correlated directly to interface hepatitis intensity; B. CD8+ TL correlated directly to interface hepatitis intensity; C. correlation between the CD4/CD8 ratio and interface hepatitis intensity; D.
The patients were grouped as low activity (85% of patients with score granding from 0 to 1 of Ishak classification17) as “?” and high activity (15% of patients with score grading from 2 and
3 of Ishak classification17) as “?”. Bars represent mean values.
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Table 2
Quantitative data of TL in portal areas related to demographic, blood chemistry, viral genotype and histological scores
Event Mean score Relation scores with
CD4+ cells/mm2 CD8+ cells/mm2 CD4/CD8 ratio
Age (years) 37.64 rs = 0.2963 rs = 0.2465 rs = -0.0284
SD ± 11.73 p = .067 p = .130 p = .864
Serum AST 2.08 r = 0.1562 r = 0.4624 r = -0.2604
SD ± 1.59 p = .342 p = .003* p = .109
Serum ALT 2.77 r = 0.0204 r = 0.3214 r = -0.1939
SD ± 1.42 p = .902 p = .046* p = .237
Serum GGT 2.21 r = 0.2154 r = 0.4555 r = -0.2279
SD ± 1.78 p = .188 p = .004* p = .163
No. patients with genotype 1 28/39 rs = 0.0810 rs = -0.0076 rs = 0.1468
% 71.79% p = .624 p = .963 p = .372
No. patients with genotype 3 8/39 rs = -0.1072 rs = -0.0649 rs = -.0671
% 20.51% p = .516 p = .694 p = .685
Histological staging (Ishak) 2.05 r = 0.2527 r = 0.2330 r = -0.0673
SD ± 1.43 p = .121 p = .153 p = .684
Portal Inflammation 1.97 r = 0.2499 r = 0.2398 r = 0.0282
SD ± 0.71 p = .125 p = .142 p = .865
Piecemeal necrosis 0.90 r = 0.3777 r = 0.3545 r = 0.0361
SD ± 0.79 p = .018* p = .027* p = .827
Focal necrosis 1.0513 r = 0.1587 r = -0.0810 r = 0.3013
SD ± 0.39 p = .335 p = .624 p = .062
r represents Pearson correlation, rs Spearman correlation and * p < 0.05
find any relationship between these demographic data and the
expression of intrahepatic TL (Table 2), possibly because of the small
number of individuals within each category.
The clinical significance of genotyping is still under
investigation3,11,28, and in this study, unlike previous studies, there was
no correlation between HVC genotypes and the CD4+ or CD8+ TL
expression in the liver32,34, possibly because of the small number of
genotypes 2 and 3 in this sample.
This study shows an important correlation between CD4+ and CD8+
TL and interface hepatitis in patients with chronic hepatitis C, thus
suggesting that these cells take part in the progression of the chronic
disease in liver, and it is a significant additional contribution for the
knowledge of action of TL in chronic hepatitis C.
RESUMO
A quantificação de CD4+ e CD8+ portal em hepatite C crônica
está relacionada com a intensidade da hepatite de interface
Introdução: A patogênese da hepatite C crônica ainda está em
discussão. Sabe-se que linfócitos T (LT) CD4+ e CD8+ são tipicamente
observados no espaço portal e peri-portal de pacientes com hepatite C
crônica, mas o conhecimento exato de suas ações no fígado, bem como
sua influência na progressão da doença hepática ainda estão em
discussão. Métodos: Os LT CD4+ e T CD8+ foram quantificados por
imunohistoquímica nos espaços porta e peri-portais em 39 biópsias
hepáticas de pacientes cronicamente infectados pelo vírus da hepatite
C. Esses dados foram associados com os dados demográficos, as
alterações histológicas, os achados laboratoriais dos pacientes com
hepatite C e com os genótipos do vírus da hepatite C. Resultados:
Houve grande quantidade tanto de LT CD4+ como de CD8+, sendo
que houve maior densidade de LTCD4+ do que CD8+ nos espaços
portal e peri-portal. Tanto o número de linfócitos T CD4+ como de
CD8+ foram diretamente relacionados com a intensidade da hepatite
de interface. Os linfócitos T CD8+ foram estatisticamente relacionados
às enzimas hepáticas. Conclusão: O encontro de numerosos linfócitos
T CD4+ e linfócitos T CD8+ no espaço-portal e peri-portal e sua
correlação com a hepatite de interface sugerem que a evolução da
hepatite C dependa da ação dos linfócitos T intra-hepáticos, ou seja,
há um mecanismo imuno-mediado na patogênese da hepatite C crônica.
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